Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,751 INR | -0.12% | +5.62% | +4.18% |
Business Summary
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Tablets
75.2
%
| 6,491 | 80.6 % | 7,543 | 75.2 % | +16.21% |
Injectables
16.7
%
| 937 | 11.6 % | 1,674 | 16.7 % | +78.56% |
Clinical Trials
6.1
%
| 442 | 5.5 % | 612 | 6.1 % | +38.57% |
Inhalation
2.0
%
| 186 | 2.3 % | 201 | 2.0 % | +8.06% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
93.6
%
| 7,592 | 94.2 % | 9,389 | 93.6 % | +23.68% |
International
6.4
%
| 464 | 5.8 % | 641 | 6.4 % | +37.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Siva Padmanabhan
CEO | Chief Executive Officer | - | - |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 03-01-31 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 23-09-30 |
Anil Kukreja
CTO | Chief Tech/Sci/R&D Officer | - | - |
Manasa Rama
CMP | Compliance Officer | - | 22-08-10 |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 21-03-31 |
Pankaj Jain
LAW | General Counsel | - | - |
Rishi Kapur
LAW | General Counsel | - | - |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 65 | 16-12-01 |
Chairman | 67 | 12-12-05 | |
Director/Board Member | 50 | 21-12-28 | |
Ankush Nandra
BRD | Director/Board Member | 52 | 20-05-17 |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 03-01-31 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 23-09-30 |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,000,000 | 3,106,045 ( 12.42 %) | 0 | 12.42 % |
Company contact information
AstraZeneca Pharma India Ltd.
Manyata Embassy Business Park Outer Ring Road, Rachenahalli
560045, Bangalore
+91 80 6774 8000
http://www.astrazeneca.inSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.18% | 1.73B | |
+34.35% | 705B | |
+30.88% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.15% | 238B | |
-3.19% | 210B | |
+10.33% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- ASTRAZEN Stock
- Company AstraZeneca Pharma India Limited